Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practicing in specific cardiology domains.
75 year old man
HIV (antiretroviral therapy)
Severe chronic kidney disease(dialysis)
Ischaemic cardiomyopathy : past myocardial infarction 1991
Apical and subcoastal TTE views showing mild tricuspid regurgitation
Organic TR due to flail leaflet
Functional TR due to severe left side-disease
Functional TR due to the PM lead
Tricuspid endocarditis secondary to PM implantation
TTE should be performed before and after PM implantation
TOE may be performed for severe TR in order to identify the mechanism
In cases of severe symptomatic tricuspid regurgitation caused by the PM lead, percutaneous or surgical material extraction with tricuspid valve repair or replacement should be discussed, depending on TR mechanism
Guidelines on the management of valvular heart disease (version 2012), Vahanian et Al., European Heart Journal
Lead-induced severe tricuspid regurgitation is a rare but severe complication of pacemaker implantation
TTE should be systematically performed before and after PM implantation
Percutaneous or surgical material extraction with tricuspid valve repair or replacement should be discussed in cases of severe symptomatic tricuspid regurgitation caused by the PM
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved